1.A significant proportion of patients with osteosarcoma belong to Li-Fraumeni cancer families.Porter D.E., Holden S.T., Steel C.M., Cohen B.B., Wallace M.R., Reid R. J. Bone Joint Surg [Br]. 74-B 883-886 (1992)
2.Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses. Philippe C.,Porter D.E., Emerton M.E., Wells D.E., Simpson A.H.R.W., Monaco A.P. Am. J. Hum. Genet. 61 520-528 (1997)
3.The neoplastic pathogenesis of solitary and Multiple Osteochondromas.Porter D.E., Simpson A.H.R.W. J. Pathol. 188 119-125 (1999)
4.The Hip in Hereditary Multiple Exostoses.Porter D.E., Benson M.K.D., Hosny G.A. J. Bone Joint Surg. [Br]. 83-B 988-995 (2001)
5.Severity of disease and risk of malignant change in Hereditary Multiple Exostoses: A genotype-phenotype study.Porter D.E., Lonie L., Fraser M., Dobson Stone C., Porter J.R., Monaco A.M., Simpson A.H.R.W. J. Bone Joint Surg. [Br]. 86-B 1041-1046 (2004)
6.Twentieth century survival from childhood osteosarcoma; trends from 1933 to 2004. L. Foster , G. F. Dall, R. Reid, H. Wallace,D. E. Porter. J Bone Joint Surg [Br] 89-B 1234-1238 (2007)
7.MRI surveillance after resection for primary musculoskeletal sarcomaA. C. Watts, K. Teoh, T. Evans, I. Beggs, J. Robb, andD. PorterJ Bone Joint Surg [Br] 90-B 484-487 (2008)
8.Survival in malignant peripheral nerve sheath tumours. A comparison between sporadic and neurofibromatosis type 1 associated tumours.D E Porter, V Prasad, L Foster, G F Dall, R Birch, R J Grimer. Sarcoma; Published online 2009 April 7. doi: 10.1155/2009/756395. (2009)
9.Forearm deformity in patients with hereditary multiple exostoses: factors associated with range of motion and radial head dislocation. Clement ND,Porter DE. J Bone Joint Surg 95:1586-92 (2013)
10.Chondrosarcoma transformation in hereditary multiple exostoses: A systematic review and clinical and cost-effectiveness of a proposed screening model. Li Fei, Clara Ngoh,Daniel E Porter.J. Bone Oncol.13:114-122 (2018)doi.org/10.1016/j.jbo.2018.09.011
